| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 23, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 49,374 | $90.40 | $4,463,523.71 | -83.3% | |
| May 23, 2018 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 2,050 | $85.76 | $175,808.00 | -100% | |
| May 23, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 15,177 | $90.00 | $1,365,930.00 | -21.0% | |
| May 11, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $85.00 | $170,002.80 | -40.6% | |
| May 8, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $81.38 | $162,760.00 | -69.4% | |
| May 7, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $81.81 | $245,430.00 | -5.0% | |
| May 1, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 13,000 | $83.04 | $1,079,500.52 | -81.2% | |
| Apr 23, 2018 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 2,050 | $85.95 | $176,197.50 | -100% | |
| Apr 12, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $85.10 | $170,190.00 | -44.8% | |
| Apr 5, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $75.20 | $225,607.00 | -1.3% |